2 weeks on semaglutide STARTING MY JOURNEY *week 1* // First injection, side effects, new appetite + work outs 30kg/66lbs down, can I stop
Description
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial Multi-receptor agonists that target the glucagon, glucose-dependent insulinotropic polypeptide (GIP), and glucagon-like peptide 1 (GLP-1) receptors may improve outcomes in type 2 diabetes because this condition is linked to hyperglycemia and obesity

Therefore, one of the main causes of brain injury is mitochondrial malfunction

Follow appetite, energy, and mood in addition to physical metrics to get the full picture

However, it's important to note that eligibility for Semaglutide treatment should be determined by a healthcare provider on an individual basis
